Literature DB >> 15327009

Should we maintain the 95 percent reference intervals in the era of wellness testing? A concept paper.

Lone G M Jørgensen1, Ivan Brandslund, Per Hyltoft Petersen.   

Abstract

The reference interval is probably the most widely used decision-making tool in clinical practice, with a modern use aiming at identifying wellness during health check and screening. Its use as a diagnostic tool is much less recognised and may be obsolete. The present study investigates the consequences of the new practice for the interpretation of prospective value, negative vs. positive, the probability of confirming wellness, and number of false results based on selected strategy for reference interval establishment. Calculations assumed normalised Gaussian-distributed reference intervals with analytical variation set to zero and absolute accuracy. Also assumed is the independency of tests. Probability for no values outside reference intervals in healthy subjects was calculated from the formula p(no) outside=(1 - p(single)) and according to the formula for repeated testing: p(one) outside =n x p(single) (1 - p(single))n-1 etc. Here n is the number of tests performed and p(single) is the probability of one result outside reference limits with the general formula p(i) outside n-i=k x p(single)i (1- p(single))n-i, with k being the binominal coefficient and i the number outside the reference intervals. Use of the 99.9 centile for health checks will increase the probability for no false from 60% to 99% for 10 tests, and from 46% to 98% for 15 tests. The probability for one false-positive result in 10 tests in a panel can be reduced from 32% to 1% if the 99.9% centile is substituted for the 95% centile. For two in 10 tests, the probability can be reduced from 8% to below 0.1%. In both cases, selection of the 99.9% centile improves the diagnostic accuracy. Reference intervals are needed as a "true" negative reference for absence of disease, and should cover the 99.9% centile of the reference distribution of an analyte to avoid false positives. For this new use, it is critical that reference persons are absolutely normal without clinical, genetic and biochemical signs of the condition being investigated. However, reference intervals cannot substitute clinical decision limits for diagnosis and medical intervention.

Entities:  

Mesh:

Year:  2004        PMID: 15327009     DOI: 10.1515/CCLM.2004.126

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Making the most of a patient's laboratory data: optimisation of signal-to-noise ratio.

Authors:  Per Hyltoft Petersen
Journal:  Clin Biochem Rev       Date:  2005-11

2.  When is "abnormal" abnormal? Dealing with the slightly out of range laboratory result.

Authors:  W S A Smellie
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

3.  More than half of abnormal results from laboratory tests ordered by family physicians could be false-positive.

Authors:  Christopher Naugler; Irene Ma
Journal:  Can Fam Physician       Date:  2018-03       Impact factor: 3.275

4.  Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence.

Authors:  Hossein Poustchi; Jacob George; Saeed Esmaili; Farzaneh Esna-Ashari; Gelayol Ardalan; Sadaf Ghajarieh Sepanlou; Seyed Moayed Alavian
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

Review 5.  The laboratory test utilization management toolbox.

Authors:  Geoffrey Baird
Journal:  Biochem Med (Zagreb)       Date:  2014-06-15       Impact factor: 2.313

6.  Does more testing in routine preoperative evaluation benefit the orthopedic patient? Case control study from a resource-constrained setting.

Authors:  Obada Hasan; Shah Fahad; Mohammad Mustafa; Pervaiz Hashmi; Shahryar Noordin
Journal:  Ann Med Surg (Lond)       Date:  2021-05-28

7.  Reference ranges for clinical electrophysiology of vision.

Authors:  C Quentin Davis; Ruth Hamilton
Journal:  Doc Ophthalmol       Date:  2021-04-21       Impact factor: 2.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.